Genetic modifiers of cystic fibrosis-related diabetes.
- Published in:
- 2013
- Publication type:
- Abstract
Works matching IS 2045712X AND DT 2013 AND VI 3 AND IP 3
Results: 28
1
2
Evaluation of Colistin susceptibility in multidrug-resistant clinical isolates from cystic fibrosis, France.
- Published in:
- 2013
- Publication type:
- Abstract
3
Risk factors for bronchiectasis in children with cystic fibrosis.
- Published in:
- 2013
- Publication type:
- Abstract
4
Eradication of chronic methicillin-resistant Staphylococcus aureus infection in cystic fibrosis patients. An observational cohort study of 11 patients.
- Published in:
- 2013
- Publication type:
- Abstract
5
Factors influencing the acquisition of Stenotrophomonas maltophilia infection in cystic fibrosis patients.
- Published in:
- Current Medical Literature: Cystic Fibrosis, 2013, v. 3, n. 3, p. 89
- Publication type:
- Article
6
Induced sputum compared to bronchoalveolar lavage in young, non-expectorating cystic fibrosis children.
- Published in:
- Current Medical Literature: Cystic Fibrosis, 2013, v. 3, n. 3, p. 88
- Publication type:
- Article
7
Assessment of early bronchiectasis in young children with cystic fibrosis is dependent on lung volume.
- Published in:
- Current Medical Literature: Cystic Fibrosis, 2013, v. 3, n. 3, p. 87
- Publication type:
- Article
8
Official American Thoracic Society workshop report: optimal lung function tests for monitoring cystic fibrosis, bronchopulmonary dysplasia, and recurrent wheezing in children less than 6 years of age.
- Published in:
- Current Medical Literature: Cystic Fibrosis, 2013, v. 3, n. 3, p. 87
- Publication type:
- Article
9
Association of lung function, chest radiographs and clinical features In infants with cystic fibrosis.
- Published in:
- Current Medical Literature: Cystic Fibrosis, 2013, v. 3, n. 3, p. 86
- Publication type:
- Article
10
Lung transplant outcomes in cystic fibrosis patients with pre-operative Mycobacterium abscessus respiratory infections.
- Published in:
- Current Medical Literature: Cystic Fibrosis, 2013, v. 3, n. 3, p. 85
- Publication type:
- Article
11
Survival benefit of lung transplant for cystic fibrosis since lung-allocation-score implementation.
- Published in:
- Current Medical Literature: Cystic Fibrosis, 2013, v. 3, n. 3, p. 85
- Publication type:
- Article
12
Effect of supervised training on FEV, in cystic fibrosis: a randomised controlled trial.
- Published in:
- Current Medical Literature: Cystic Fibrosis, 2013, v. 3, n. 3, p. 84
- Publication type:
- Article
13
Hyaluronic acid improves the tolerability of hypertonic saline in the chronic treatment of cystic fibrosis patients: a multicenter, randomized, controlled clinical trial.
- Published in:
- Current Medical Literature: Cystic Fibrosis, 2013, v. 3, n. 3, p. 83
- Publication type:
- Article
14
Efficacy and safety of ivacaftor in patients aged 6 to 11 years with cystic fibrosis with a G551D mutation.
- Published in:
- Current Medical Literature: Cystic Fibrosis, 2013, v. 3, n. 3, p. 82
- Publication type:
- Article
15
Effects of ivacaftor on severely ill patients with cystic fibrosis carrying a G551D mutation.
- Published in:
- Current Medical Literature: Cystic Fibrosis, 2013, v. 3, n. 3, p. 82
- Publication type:
- Article
16
A pharmacokinetics and safety comparison of a highly concentrated tobramycin solution with TOBI.
- Published in:
- Current Medical Literature: Cystic Fibrosis, 2013, v. 3, n. 3, p. 81
- Publication type:
- Article
17
Hypertonic saline is effective in the prevention and treatment of mucus obstruction but not airway inflammation in mice with chronic obstructive lung disease.
- Published in:
- Current Medical Literature: Cystic Fibrosis, 2013, v. 3, n. 3, p. 80
- Publication type:
- Article
18
Mechanism-based corrector combination restores AF508-CFTR folding and function.
- Published in:
- Current Medical Literature: Cystic Fibrosis, 2013, v. 3, n. 3, p. 79
- Publication type:
- Article
19
Therapy of CF-patients with amitriptyline and placebo - a randomised, double-blind, placebo-controlled Phase lib multicenter, cohort-study.
- Published in:
- Current Medical Literature: Cystic Fibrosis, 2013, v. 3, n. 3, p. 78
- Publication type:
- Article
20
New co-spray-dried tobramycin nanoparticles-darithromycin inhaled powder systems for lung Infection therapy in cystic fibrosis patients.
- Published in:
- Current Medical Literature: Cystic Fibrosis, 2013, v. 3, n. 3, p. 77
- Publication type:
- Article
21
Acute inhibition of the cystic fibrosis transmembrane conductance regulator (CFTR) CI channel by thyroid hormones involves multiple mechanisms.
- Published in:
- Current Medical Literature: Cystic Fibrosis, 2013, v. 3, n. 3, p. 76
- Publication type:
- Article
22
ENaC silencing as a strategy to correct the airway surface fluid deficit in cystic fibrosis.
- Published in:
- Current Medical Literature: Cystic Fibrosis, 2013, v. 3, n. 3, p. 76
- Publication type:
- Article
23
Regulated recycling of mutant CFTR partially restored by pharmacological treatment.
- Published in:
- Current Medical Literature: Cystic Fibrosis, 2013, v. 3, n. 3, p. 75
- Publication type:
- Article
24
Skin pretreatment with microneedles prior to pilocarpine iontophoresis increases sweat production.
- Published in:
- Current Medical Literature: Cystic Fibrosis, 2013, v. 3, n. 3, p. 74
- Publication type:
- Article
25
Next generation diagnosis of cystic fibrosis and CFTR-related disorders by targeted multiplex high-coverage resequencing of CFTR.
- Published in:
- Current Medical Literature: Cystic Fibrosis, 2013, v. 3, n. 3, p. 73
- Publication type:
- Article
26
International Events 2013/14.
- Published in:
- 2013
- Publication type:
- Proceeding
27
A New Era in Cystic Fibrosis Treatment: Small-Molecule Therapy.
- Published in:
- Current Medical Literature: Cystic Fibrosis, 2013, v. 3, n. 3, p. 65
- By:
- Publication type:
- Article
28
Foreword.
- Published in:
- Current Medical Literature: Cystic Fibrosis, 2013, v. 3, n. 3, p. IV
- Publication type:
- Article